Sign in

CIK 0001367083

  • Non-accelerated filer
  • Smaller reporting company

Sonoma Pharmaceuticals, Inc.

Sign in to watch
Ticker
SNOA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
680423298
Phone
+1 800-759-9305
Business address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
Former names
Oculus Innovative Sciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2009-06-16 Burlingame Robert Director Other acquisition +435,897 1,294,931
2009-06-01 Burlingame Robert Director Purchase +569,801 $1.17 $667K 859,034
2009-06-01 Burlingame Robert Director Purchase · Warrant (right to buy) +333,333 927,222
2009-06-01 Burlingame Robert Director Purchase · Warrant (right to buy) +444,445 1,371,667
2009-03-10 Schutz James J Vice President Grant or award · Stock Option (right to buy) +184,500 $1.09 $201K 434,500
2009-03-10 Miller Robert E Chief Financial Officer Grant or award · Stock Option (right to buy) +184,500 $1.09 $201K 294,564
2009-03-10 Conley Richard K Director Grant or award · Stock Option (right to buy) +60,000 $1.09 $65K 279,570
2009-03-10 French Gregory M Director Grant or award · Stock Option (right to buy) +60,000 $1.09 $65K 208,906
2009-03-10 Alimi Hojabr Chief Executive Officer Grant or award · Stock Option (right to buy) +291,000 $1.09 $317K 658,070
2009-03-06 Alimi Hojabr Chief Executive Officer Sale −13,200 $1.05 $14K 1,011,250
2009-03-05 Alimi Hojabr Chief Executive Officer Sale −7,800 $1.14 $9K 1,024,450
2009-03-04 Burlingame Robert Director Purchase +218,234 $1.17 $255K 289,233
2009-03-04 Burlingame Robert Director Purchase · Warrant (right to buy) +166,667 366,667
2009-03-04 Burlingame Robert Director Purchase · Warrant (right to buy) +222,222 588,889
2009-03-04 Alimi Hojabr Chief Executive Officer Sale −17,800 $1.16 $21K 1,032,250
2009-03-03 Alimi Hojabr Chief Executive Officer Sale −6,200 $1.23 $8K 1,050,050
2009-03-03 Alimi Hojabr Chief Executive Officer Exercise or conversion · Stock Options (Right to Buy) +75,000 $0.15 $11K 1,056,250
2008-12-09 French Gregory M Director Grant or award · Stock Option (right to buy) +25,000 25,000
2008-12-09 Burlingame Robert Director Grant or award · Stock Option (right to buy) +25,000 25,000
2008-12-09 Birnbaum Jay E Director Grant or award · Stock Option (right to buy) +25,000 25,000

Page 17 of 19 · 377 trades